FI249774A - - Google Patents

Info

Publication number
FI249774A
FI249774A FI2497/74A FI249774A FI249774A FI 249774 A FI249774 A FI 249774A FI 2497/74 A FI2497/74 A FI 2497/74A FI 249774 A FI249774 A FI 249774A FI 249774 A FI249774 A FI 249774A
Authority
FI
Finland
Application number
FI2497/74A
Inventor
G Dahlhausen
H-W Dibbern
W Fuelbert
G Ross
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5890849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI249774(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI249774A publication Critical patent/FI249774A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI2497/74A 1973-08-28 1974-08-26 FI249774A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2343218A DE2343218C2 (de) 1973-08-28 1973-08-28 Furosemid enthaltende Pellets

Publications (1)

Publication Number Publication Date
FI249774A true FI249774A (fi) 1975-03-01

Family

ID=5890849

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2497/74A FI249774A (fi) 1973-08-28 1974-08-26

Country Status (17)

Country Link
US (1) US4324779A (fi)
JP (1) JPS563849B2 (fi)
AT (1) AT344914B (fi)
BE (1) BE819294A (fi)
CA (1) CA1063024A (fi)
DE (1) DE2343218C2 (fi)
DK (1) DK155173B (fi)
EG (1) EG14662A (fi)
FI (1) FI249774A (fi)
FR (1) FR2242076B1 (fi)
GB (1) GB1478715A (fi)
HU (1) HU171769B (fi)
IL (1) IL45521A (fi)
MX (1) MX3585E (fi)
NL (1) NL7411269A (fi)
SE (1) SE7410788L (fi)
ZA (1) ZA745443B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65910C (fi) * 1976-11-26 1984-08-10 Pennwalt Corp Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
DE3305935C2 (de) * 1983-02-21 1985-05-30 Medice Chem.-Pharm. Fabrik Pütter GmbH & Co KG, 5860 Iserlohn Kaliumneutrales Saluretikum mit antihypertensiver Wirkung
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
SE460947B (sv) * 1986-08-26 1989-12-11 Lejus Medical Ab En multiple-unit-dos komposition av l-dopa
JPH01130957U (fi) * 1988-02-29 1989-09-06
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US20070059358A1 (en) * 2003-07-02 2007-03-15 Tianjin Tasly Pharmaceutical Co., Ltd., China Matrix adjuvants and the drop pills prepared with them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3361632A (en) * 1964-05-08 1968-01-02 Hoechst Ag Medicinal preparations having a protracted activity and method of making them
US3456049A (en) * 1965-05-25 1969-07-15 Ciba Geigy Corp Gradual-release tablet
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung

Also Published As

Publication number Publication date
CA1063024A (en) 1979-09-25
IL45521A0 (en) 1974-11-29
DE2343218C2 (de) 1986-08-07
DK455274A (fi) 1975-04-28
ZA745443B (en) 1975-08-27
FR2242076B1 (fi) 1978-07-28
ATA694274A (de) 1977-12-15
DK155173B (da) 1989-02-27
FR2242076A1 (fi) 1975-03-28
AU7272874A (en) 1976-03-04
HU171769B (hu) 1978-03-28
US4324779A (en) 1982-04-13
NL7411269A (nl) 1975-03-04
DE2343218A1 (de) 1975-04-03
IL45521A (en) 1978-07-31
MX3585E (es) 1981-03-20
JPS563849B2 (fi) 1981-01-27
JPS5076217A (fi) 1975-06-21
BE819294A (fr) 1975-02-28
SE7410788L (fi) 1975-03-03
GB1478715A (en) 1977-07-06
EG14662A (en) 1984-09-30
AT344914B (de) 1978-08-25

Similar Documents

Publication Publication Date Title
AR201758A1 (fi)
AU476761B2 (fi)
AU465372B2 (fi)
AR201235Q (fi)
AR201231Q (fi)
AU474593B2 (fi)
AU474511B2 (fi)
AU474838B2 (fi)
AU465453B2 (fi)
AU465434B2 (fi)
AU471343B2 (fi)
FR2242076B1 (fi)
AU450229B2 (fi)
AU476714B2 (fi)
AR201229Q (fi)
AU476696B2 (fi)
AU472848B2 (fi)
AU466283B2 (fi)
AR199451A1 (fi)
AU477823B2 (fi)
AU461342B2 (fi)
AU476873B1 (fi)
AU447540B2 (fi)
AU477824B2 (fi)
AR210729A1 (fi)